Table 1 Demographic and clinical characteristics of the overall study population and by year of diagnosis cohort
Total population (N = 12,865) | Year of diagnosis cohort | |||||
|---|---|---|---|---|---|---|
2000–2002 (n = 2380) | 2003–2005 (n = 2808) | 2006–2008 (n = 2926) | 2009–2011 (n = 2881) | 2012–2013 (n = 1870) | ||
Age at diagnosis (years), median (IQR) | 67 (59–74) | 66 (58–73) | 67 (59–74) | 67 (59–74) | 67 (59–75) | 68 (60–74) |
Male, n (%) | 7599 (59.1) | 1448 (60.8) | 1703 (60.6) | 1731 (59.2) | 1666 (57.8) | 1051 (56.2) |
Race/ethnicity, n (%) | ||||||
Asian | 503 (3.9) | 82 (3.5) | 111 (4.0) | 120 (4.1) | 125 (4.3) | 65 (3.5) |
Black | 1734 (13.5) | 316 (13.3) | 330 (11.8) | 413 (14.1) | 377 (13.1) | 298 (15.9) |
White | 10,168 (79.0) | 1891 (79.5) | 2264 (80.6) | 2300 (78.6) | 2281 (79.2) | 1432 (76.6) |
Other | 453 (3.5) | 89 (3.7) | 101 (3.6) | 92 (3.1) | 97 (3.4) | 74 (4.0) |
Unknown | 7 (0.1) | 2 (0.1) | 2 (0.1) | 1 (0.0) | 1 (0.0) | 1 (0.1) |
NSCLC stage, n (%) | ||||||
Stage IIIA | 5159 (40.1) | 791 (33.2) | 1047 (37.3) | 1198 (40.9) | 1254 (43.5) | 869 (46.5) |
Stage IIIB | 7706 (59.9) | 1589 (66.8) | 1761 (62.7) | 1728 (59.1) | 1627 (56.5) | 1001 (53.5) |
Histology, n (%) Squamous Non-squamous | 4797 (37.3) 8068 (62.7) | 876 (36.8) 1504 (63.2) | 908 (32.3) 1900 (67.7) | 970 (33.2) 1956 (66.9) | 1200 (41.7) 1681 (58.4) | 843 (45.1) 1027 (54.9) |
Year of diagnosis, n (%)* | ||||||
2000 | 631 (4.9) | 631 (26.5) | ||||
2001 | 865 (6.7) | 865 (36.3) | ||||
2002 | 884 (6.9) | 884 (37.1) | ||||
2003 | 872 (6.8) | 872 (31.1) | ||||
2004 | 984 (7.7) | 984 (35.0) | ||||
2005 | 952 (7.4) | 952 (33.9) | ||||
2006 | 933 (7.3) | 933 (31.9) | ||||
2007 | 988 (7.7) | 988 (33.8) | ||||
2008 | 1005 (7.8) | 1005 (34.3) | ||||
2009 | 962 (7.5) | 962 (33.4) | ||||
2010 | 931 (7.2) | 931 (32.3) | ||||
2011 | 988 (7.7) | 988 (34.3) | ||||
2012 | 933 (7.3) | 933 (49.9) | ||||
2013 | 937 (7.3) | 937 (50.1) | ||||